D-0515-2017 Class II Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-0515-2017 was initiated by Sandoz Inc on Feb 10, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Oct 24, 2017).

Recall details

Product Type
Drugs
Report Date
Mar 15, 2017
Initiation Date
Feb 10, 2017
Termination Date
Oct 24, 2017
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Pioglitazone and Glimepiride Tablets, USP, 30 mg/4 mg, 30 count bottles, Rx only, Manufactured by Lek Pharmaceuticals d.d., Verovskova Ulica 57, Ljubljana, - SI-1526, Slovenia --- NDC 0781-5635-31

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

Lot FY3669 with expiry 11/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0515-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0515-2017. Report a data issue: hello@regdatalab.com.